TotalMarketCap

GSK

GSKNYSE United KingdomHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$101.904 B

$50.38 -1.50%

Close of 6 Nov 2026

As of 6 Nov 2026, GSK (GSK) has a market capitalization of $101.9B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

4,315,445,026

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #11Bristol Myers SquibbBMY$129.3B
  2. #12SanofiSNY$114.3B
  3. #13GSKGSK$101.9B
  4. #14Regeneron PharmaceuticalsREGN$93.4B
  5. #15Takeda PharmaceuticalTAK$67.1B

What if GSK were worth as much as…

Open the what-if tool →

Gold $28.2T

$13,959.95

Per share 277× higher

Bitcoin $1.53T

$755.35

Per share 15.0× higher

Apple $5.02T

$2,479.74

Per share 49.2× higher

Or at a round number

$200.0B$500.0B$1.00T$2.00T

Where these numbers come from

Share counts and financials for GSK are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.